Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan
- 7 February 2024
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 40 (2) , e3773
Abstract
Aims: Sodium–glucose cotransporter‐2 inhibitors (SGLT2is) are proposed to alleviate the development of inflammatory eye diseases. However, the association between SGLT2i and retinal vascular occlusion remains unclear. Therefore, this study aims to explore the effects of SGLT2i on the incidence of retinal vascular occlusion.Materials and Methods: This retrospective cohort study analysed electronic medical records data from the largest multi‐institutional database in Taiwan. Individuals who initiated SGLT2is and dipeptidyl peptidase 4 inhibitors (DPP4is) between 2016 and 2019 were included in our analysis. To conduct a homogenous comparison, inverse probability of treatment weighting with propensity scoring was employed. The primary outcome was retinal vascular occlusion, and the secondary outcomes were retinal vascular occlusion‐related complications (macular oedema, vitreous haemorrhage, and tractional retinal detachment) and conditions requiring vitreoretinal intervention (intravitreal injection, retinal laser therapy, and vitrectomy).Results: In total, 12,074 SGLT2i users and 39,318 DPP4i users were included. The incidence rate of retinal vascular occlusion in the SGLT2i and DPP4i groups was 1.2 (95% confidence interval [CI], 0.9–1.4) and 1.6 (95% CI, 1.3–1.8) events per 1000 person‐years, respectively, which yielded a subdistribution hazard ratio (SHR) of 0.74 (95% CI, 0.55–0.99). Similar risk reductions were observed in the retinal vascular occlusion‐related complications (SHR, 0.76; 95% CI, 0.69–0.84) and conditions requiring vitreoretinal intervention (SHR, 0.84; 95% CI, 0.77–0.94).Conclusions: In this multi‐institutional study in Taiwan, SGLT2i use was associated with a reduced risk of retinal vascular occlusion. Further prospective studies are required to ascertain this association.Keywords
This publication has 34 references indexed in Scilit:
- Diabetic retinopathy, metabolic memory and epigenetic modificationsVision Research, 2017
- Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin–angiotensin system blockadeBlood Pressure, 2015
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Extracellular matrix, gap junctions, and retinal vascular homeostasis in diabetic retinopathyExperimental Eye Research, 2015
- Diabetes, Fasting Glucose, and the Risk of GlaucomaOphthalmology, 2015
- Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesisAtherosclerosis, 2014
- Inflammation in Retinal Vein OcclusionInternational Journal of Inflammation, 2013
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Retinal Vascular OcclusionsDeutsches Ärzteblatt international, 2008
- Ocular Neovascularization With Retinal Vascular OcclusionArchives of Ophthalmology (1950), 1982